National Academy of Agricultural Sciences (NAAS)
|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Campylobacteriosis is considered an emerging public health problem with a higher morbidity and mortality rate and a significant impediment to socioeconomic development worldwide. Pigs act as a major reservoir host of Campylobacter spp. The organism colonizes the intestinal tract and can persist for the entire lifespan in pigs without any disease manifestation and pose a significant threat to farm biosecurity. The emergence of multidrug resistant strains of Campylobacter spp. in recent years has been attributed to the indiscriminate use of antimicrobial agents in animal production. In this study, the weekly excretion pattern in piglets was analysed in a government farm in Thrissur. The piglets were found to excrete Campylobacter jejuni from the fourth week of age with possible sources of contamination from dams and paddock environment. By the end of tenth week, piglets (66.67 per cent) excreted C. coli predominantly. Pigs were also carrying organisms with a regular excretion pattern (45 per cent). Environmental contamination also played a major role in transmission of Campylobacter spp. as 20 per cent of feed and soil samples and 30 per cent of wallowing tank water samples were positive for Campylobacter coli. Wild birds also acted as a source of paddock contamination with a prevalence rate of 30 per cent. Campylobacter jejuni isolates showed higher resistance against azithromycin (97.37 per cent), oxytetracycline (93.42 per cent), co-trimoxazole (88.16 per cent) and ofloxacin (68.42 per cent) and cent per cent resistance against ceftazidime. Campylobacter coli isolates showed cent per cent resistance against azithromycin, ceftazidime, co-trimoxazole and higher resistance against chloramphenicol (87.50 per cent), ciprofloxacin (87.50 per cent), doxycycline (87.50 per cent), oxytetracycline (83.33 per cent) and erythromycin (83 per cent).
Citations |
 |
 |
 |
 |
